Genmab Announces Financial Results for the First Quarter of 2017
May 10, 2017 11:12 ET
|
Genmab A/S
May 10, 2017; Copenhagen, Denmark;
Interim Report for the First Quarter of 2017
Highlights
USD 255 million in net sales of DARZALEX® (daratumumab); resulting in royalty income of DKK 211...
Genmab Announces Financial Results for the First Quarter of 2017
May 10, 2017 11:03 ET
|
Genmab A/S
May 10, 2017; Copenhagen, Denmark;
Interim Report for the First Quarter of 2017
Highlights
USD 255 million in net sales of DARZALEX® (daratumumab); resulting in royalty income of DKK 211...
Genmab Announces New Phase III Combination Study of Daratumumab in Multiple Myeloma
April 28, 2017 09:26 ET
|
Genmab A/S
Company Announcement
Phase III study of daratumumab in combination with pomalidomide and dexamethasone in relapsed and refractory multiple myeloma
Collaborative study between European...
Genmab Announces European Marketing Authorization for DARZALEX® (daratumumab) for Relapsed or Refractory Multiple Myeloma
April 28, 2017 06:22 ET
|
Genmab A/S
Company Announcement
DARZALEX approved in Europe in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone in patients who have received at least one prior therapy...
Genmab Announces Data to be Presented at 2017 ASCO Annual Meeting
April 20, 2017 10:11 ET
|
Genmab A/S
Media Release
8 abstracts on Genmab programs scheduled for presentation at ASCO
Two daratumumab oral presentations and five daratumumab poster presentations
Copenhagen, Denmark; April...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2017
April 18, 2017 06:55 ET
|
Genmab A/S
Company Announcement
Net sales of DARZALEX in the first quarter of 2017 totaled USD 255 million
Genmab will receive royalties on worldwide net sales from Janssen Biotech,...
Selskabsvedtægter for Genmab A/S
April 05, 2017 08:30 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 4. april 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Articles of Association for Genmab A/S
April 05, 2017 08:30 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated April 4, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel Curtis...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
April 04, 2017 12:14 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; April 4, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 176,843 shares as a consequence of the exercise of employee...
Selskabsvedtægter for Genmab A/S
April 03, 2017 12:53 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 29. marts 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...